Company / Revenue
Viatris Revenue History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue
$14.3B
FY2025
5-year range
$11.5B / $15.4B
FY2021-FY2025
Trend
-3.0%
vs FY2024
Sector context
#12 of 155
Health Care
What the data says
Among 155 Health Care companies, Viatris is in the top 8% for revenue. Revenue has fluctuated over the past 8 years, ranging from $11.4B in FY2020 to $15.4B in FY2023.
Based on SEC 10-K filings.
$14.3B in FY2025 with a 5-year CAGR of +4.6%. Top quartile in the Health Care sector.
Declined from $15.4B to $14.3B over the past 2 years.
Health Care sector context is included.
Revenue over time
Growth rates
- 3-Year CAGR
- +6.2%
- 5-Year CAGR
- +4.6%
- 10-Year CAGR
- -
Sector benchmark
Top 8% in Health CareTop 8% of 155This company $14.3B Sector average $4.5B
▼
+219.9% above sector average
Key checks
Key Insights
- 5-year CAGR of +4.6%, indicating consistent growth.
- In FY2025, revenue decreased 3.0% year-over-year.
- Ranks #12 out of 155 companies in the Health Care sector.
- Peak revenue was recorded in FY2023.
Company context
Key Data Points
- Altman Z-Score 0.48 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $14.3B | -3.0% |
| FY2024 | $14.7B | -4.5% |
| FY2023 | $15.4B | +29.1% |
| FY2022 | $11.9B | +3.9% |
| FY2021 | $11.5B | +0.6% |
| FY2020 | $11.4B | -0.6% |
| FY2019 | $11.5B | +0.6% |
| FY2018 | $11.4B | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026